Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medi Assist Health Ser L (MEDIASSIST.NS)
Bengaluru, IN
Founded in 2000 and headquartered in Bengaluru, India, Medi Assist Healthcare Services Limited, alongside its subsidiaries, provides third-party administration (TPA) services both within India and globally. Operating as a health-tech and insurance-tech enterprise, the company focuses on overseeing health benefit management for various client groups, including employers, individual retail customers, and public health programs, primarily supporting insurance carriers. Beyond its core TPA functions, Medi Assist offers a comprehensive range of services. These encompass business support, health management, consultancy, and contact center assistance, among other related support within the healthcare and health insurance sectors. The company also furnishes insurance providers with pre-policy medical examinations and other ancillary services, while extending policy administration assistance to governments for their public health initiatives.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.79% | +5.03% | +13.05% | -1.86% | -13.97% | -13.82% | -16.09% | -14.68% | -14.68% | -14.68% | -14.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Investment - Banking & Investment Services: +23.9%+25.1% ★ Q1'26: +28.1% (vs Q1'25)
-
EPS growth Investment - Banking & Investment Services: +31.6%-5.5% Q1'26: +141.1% (vs Q1'25)
-
FCF margin FCF growth · Investment - Banking & Investment Services: +22.1%+8.7% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Investment - Banking & Investment Services: +33.7%+10.8% Q1'26: +11.3% (vs Q1'25)
-
ROIC Investment - Banking & Investment Services: +2.7%+14.6% ★ Q1'26: +16.4% (vs Q1'25)
-
Share dilution Investment - Banking & Investment Services: +0.1%+2.4% Q1'26: +3.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Investment - Banking & Investment Services: -0.48×0.31× ★ Q1'26: 0.28× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
6.35B
est: 6.35B (+0.0%)
|
7.23B
est: 7.28B (-0.6%)
|
9.10B
9.05B – 9.12B
+25.0% YoY
|
10.58B
10.37B – 10.74B
+16.3% YoY
|
12.04B
11.58B – 12.38B
+13.8% YoY
|
| EBITDA |
1.31B
est: 1.65B (-21.0%)
|
1.78B
est: 1.90B (-6.1%)
|
2.37B
2.36B – 2.38B
+25.0% YoY
|
2.76B
2.70B – 2.80B
+16.3% YoY
|
3.14B
3.02B – 3.22B
+13.8% YoY
|
| EBIT |
875.08M
est: 1.19B (-26.2%)
|
1.22B
est: 1.36B (-10.2%)
|
1.70B
1.69B – 1.70B
+25.0% YoY
|
1.98B
1.94B – 2.01B
+16.3% YoY
|
2.25B
2.16B – 2.31B
+13.8% YoY
|
| Net Income |
669.39M
|
908.79M
est: 902.90M (+0.7%)
|
565.78M
511.25M – 620.32M
-37.3% YoY
|
998.57M
975.78M – 1.02B
+76.5% YoY
|
1.41B
1.12B – 1.50B
+41.2% YoY
|
| SGA |
698.18M
est: 596.57M (+17.0%)
|
370.98M
est: 683.94M (-45.8%)
|
854.86M
850.53M – 857.58M
+25.0% YoY
|
994.46M
974.51M – 1.01B
+16.3% YoY
|
1.13B
1.09B – 1.16B
+13.8% YoY
|
| EPS |
9.71
|
12.91
est: 12.77 (+1.1%)
|
8.00
7.23 – 8.77
-37.3% YoY
|
14.17
13.80 – 14.44
+77.1% YoY
|
18.80
15.80 – 21.20
+32.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Goldman Sachs India Equity ETF GIND | 0.30% | 505.1K | 0.75% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 11.2K | 0.42% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 202.4K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 113.4K | 0.29% |
| 5 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.00% | 2.9K | 0.35% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 102.5K | 0.28% |
| 7 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 68.5K | 0.33% |
| 8 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.00% | 932.40 | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vikram Jit Singh Chhatwal | Chairman | 31M | — |
| Satish Gidugu | Chief Executive Officer & Whole Time Director | 21M | male |
| Prashant Shrivastava | Senior Vice President of Human Resources | — | male |
| Praveen Samariya | Chief Technology Officer | — | male |
| Rashmi Vasudev | Company Secretary & Compliance Officer | — | female |
| Sandeep R. Daga | Chief Financial Officer | — | male |
| Vijay Sankaran | Chief Claims Officer | — | — |
| Nicholas Taylor | Chief Operating Officer of Mayfair We Care | — | male |
| Vinaya Natarajan | Head of Legal & Compliance | — | female |
| Nikhil Chopra | Chief Business Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MEDIASSIST.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
